Codify — Article

MIND Our Veterans Act requires validated mental‑health screens in separation assessments

Mandates the VA–DoD Joint Executive Committee validate key mental‑health screens, evaluate adding substance‑use screening, and meet 120‑day implementation/reporting deadlines.

The Brief

The MIND Our Veterans Act directs the Department of Veterans Affairs–Department of Defense Joint Executive Committee to ensure that mental‑health screens used in the separation health assessment for separating service members are validated tools. The bill singles out PTSD, alcohol use, and violence‑risk screens for modification to reach validated status and requires the Committee to consider including substance‑use screening as a mental‑health measure.

The Act also imposes 120‑day deadlines: the Committee must report to congressional committees on whether to include a substance‑use screen, and the Secretary of Defense must ‘‘fully implement’’ the separation health assessment within 120 days. For policy teams, this law changes the evidentiary standard for screening instruments, sets tight timelines for operational changes, and shifts oversight of separation‑era mental‑health diagnostics toward standardized, validated tools.

At a Glance

What It Does

Requires the VA–DoD Joint Executive Committee to ensure PTSD, alcohol use, and violence risk screens in the separation health assessment are validated (either by validating existing tools or replacing them with validated ones). It also directs the Committee to evaluate and report on adding a substance‑use screen and orders the Secretary of Defense to implement the separation health assessment within 120 days.

Who It Affects

Directly affects the VA–DoD Joint Executive Committee, the Department of Defense (including military medical and transition‑care personnel), and clinicians who administer separation health assessments. It also matters to separating service members and veteran‑serving organizations that rely on screening results for continuity of care.

Why It Matters

The bill raises the evidentiary bar for transition screening tools and forces a near‑term operational rollout, which could change the sensitivity, consistency, and legal defensibility of diagnoses made at separation. Compliance officers, program managers, and clinical leads should expect validation work, training, and updated protocols.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The bill focuses narrowly on the separation health assessment used when service members leave active duty. It starts from a simple premise: screens used at separation for mental‑health purposes should be validated instruments.

To make that happen, the Joint Executive Committee — the body set up under 38 U.S.C. 320 that coordinates VA and DoD clinical policies — must ensure three categories of screens (PTSD, alcohol use, and violence risk) are modified into validated tools. The statute allows two routes: commissioning validation studies for existing screens or swapping in already validated instruments.

On substance use, the Committee must treat screening for substance‑use disorders as a mental‑health screen and decide whether to add it to the formal separation assessment. The Committee has 120 days from enactment to submit a report to the Armed Services and Veterans’ Affairs committees in both Houses explaining the justification for inclusion or exclusion.

That report is the Committee’s opportunity to lay out evidence, resource needs, and any operational concerns tied to adding substance‑use screening.Separately, the bill directs the Secretary of Defense, guided by the Under Secretary for Personnel and Readiness, to ‘‘fully implement’’ the separation health assessment within 120 days of enactment. The text does not appropriate funds or specify metrics for implementation; it sets a deadline for action.

The statute closes with definitions tying ‘‘Joint Executive Committee’’ to the 38 U.S.C. 320 body and naming the congressional committees that will receive the substance‑use report.Practically, the law forces clinical and program teams to reconcile clinical validity with operational realities: teams must either demonstrate the psychometric properties of current instruments or adopt validated alternatives, update procedures, train staff, and align how data are recorded and shared between DoD and VA. Because the bill prescribes timelines but not funding or enforcement penalties, much of its effect will depend on how the Committee and DoD prioritize validation work and implementation planning.

The Five Things You Need to Know

1

The bill requires modification of the PTSD, alcohol‑use, and violence‑risk screens used in the separation health assessment so each is a validated tool — by validating an existing screen or replacing it with an already validated instrument.

2

The Joint Executive Committee must treat substance‑use screening as a mental‑health screen and decide whether to include it in the separation health assessment; it must submit a written justification to the Armed Services and Veterans’ Affairs committees within 120 days.

3

The Secretary of Defense, under guidance from the Under Secretary for Personnel and Readiness, must fully implement the separation health assessment within 120 days of enactment.

4

The bill ties the term ‘Joint Executive Committee’ to the VA‑DoD Joint Executive Committee established under 38 U.S.C. 320 and explicitly names the congressional committees that will receive the substance‑use screening report.

5

The statute sets process‑focused requirements (validation, evaluation, reporting, and an implementation deadline) but does not appropriate money, prescribe performance metrics, or create penalties for noncompliance.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Establishes the Act’s short titles: the Medical Integrity in Necessary Diagnostics for Our Veterans Act of 2025 and the MIND Our Veterans Act of 2025. This is a formal naming provision; it carries no substantive requirements but is how the statute will be cited in law and guidance.

Section 2(a)

Sense of Congress on validated screening and substance use

Sets out Congress’s view that transitioning service members need effective pre‑separation mental‑health screening, that all mental‑health screens in the separation assessment should be validated, and that screening for substance use should be considered part of mental‑health screening. The subsection is hortatory — it signals congressional priorities that will frame later mandatory provisions and oversight.

Section 2(b)

Validation requirement for three named screens

Directs the Joint Executive Committee to ensure the PTSD, alcohol‑use, and violence‑risk screens in the separation health assessment are modified to be validated tools. The provision explicitly allows two compliance paths: conducting validation studies on the existing instruments or replacing them with already validated screens. For implementers, this means either proving psychometric adequacy or selecting and integrating different instruments.

3 more sections
Section 2(c)

Substance‑use screening: evaluation and report

Requires the Committee to treat substance‑use screening as a mental‑health screen and to assess whether to include such a screen in the separation health assessment, including steps to incorporate a validated screen if appropriate. Crucially, it imposes a 120‑day reporting deadline to the Armed Services and Veterans’ Affairs committees explaining the justification for including or not including the substance‑use screen — a deliverable that will shape congressional oversight and potential follow‑on mandates.

Section 2(d)

120‑day implementation deadline for the separation health assessment

Orders the Secretary of Defense, guided by the Under Secretary for Personnel and Readiness, to ‘‘fully implement’’ the separation health assessment within 120 days of enactment. The statute does not define ‘fully implement,’ nor does it attach funding or success metrics, so implementation will depend on internal DoD plans and the Committee’s validation work.

Section 2(e)

Definitions and congressional recipients

Defines ‘‘appropriate congressional committees’’ as the Armed Services and Veterans’ Affairs committees of both Chambers and cross‑references the Joint Executive Committee to the body established by 38 U.S.C. 320. These definitions clarify oversight channels and identify the institutional stewards for the required report.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Veterans across all five countries.

Explore Veterans in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Separating service members — they stand to gain more reliable, validated screening that can improve referral accuracy to VA services and reduce missed diagnoses during the transition.
  • VA and DoD clinicians and care coordinators — standardized validated tools can provide more consistent diagnostic signals, improving clinical decisionmaking and handoffs between military and VA care.
  • Veteran service organizations and transition‑care advocates — the reporting and validation requirements create leverage for stronger transition screening and clearer evidence to support policy changes.
  • Program managers and quality‑assurance teams — validated instruments improve data quality for evaluation, benchmarking, and continuous improvement of transition mental‑health programs.

Who Bears the Cost

  • Department of Defense and the Joint Executive Committee — they must conduct validation studies or select and integrate validated screens, update protocols, and absorb administrative and training costs (the bill does not fund these activities).
  • Military medical personnel and transition counselors — implementation will increase training, documentation, and potentially screening time during separation processing.
  • Separating service members (operationally) — adding validated or additional screens, including substance‑use questions, may lengthen separation processing and raise career and privacy concerns that influence disclosure.
  • Congressional oversight staff and committee resources — the 120‑day report and anticipated follow‑up hearings will require staff time to evaluate technical validation evidence and operational readiness.

Key Issues

The Core Tension

The central dilemma is between raising clinical standards (using validated screens to improve diagnostic accuracy and data quality) and the practical/behavioral consequences of doing so quickly: validated instruments and added substance‑use questions can improve detection but may lengthen separations, require funding and training, and discourage honest disclosure if members fear career or medical consequences. The statute prioritizes accuracy and standardization but gives little guidance on mitigating the operational and privacy trade‑offs that can undermine uptake.

The bill raises several implementation questions that could blunt or delay its intended effects. First, ‘‘validated’’ is a technical term that requires decisions about what validation standard applies (e.g., sensitivity/specificity thresholds, target populations, or cross‑cultural validity).

Running validation studies takes time and sample sizes that may exceed a 120‑day window, so DoD will likely need to rely on existing validated instruments rather than re‑validate current screens within the statutory deadlines.

Second, including substance‑use screening at separation has clinical value but creates real confidentiality, career, and disclosure trade‑offs. Service members may underreport substance use if they fear administrative or medical consequences, which reduces screening sensitivity even if the instrument is psychometrically strong.

The statute is silent on protections for disclosure, how positive screens will be handled, or whether screening is confidential for referral purposes only.

Finally, the law sets deadlines without dedicated funding or metrics and uses the imprecise mandate to ‘‘fully implement’’ the separation health assessment. That leaves room for uneven implementation across services, variant local protocols, and potential misalignment between what the Joint Executive Committee endorses and what commanders operationalize.

Data sharing, record‑keeping standards, and interoperability with VA systems will determine whether the validation effort translates into better care — and those operational elements are not specified in the bill.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.